Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin & Pontus Karling. (2019) Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 54:2, pages 152-157.
Read now
Read now
Fei Sjöberg, Dilip Kumar Malipatlolla, Piyush Patel, Ulrica Wilderäng, Marie Kalm, Gunnar Steineck & Cecilia Bull. (2018) Elastase as a potential biomarker for radiation-induced gut wall injury of the distal bowel in an experimental mouse model. Acta Oncologica 57:8, pages 1025-1030.
Read now
Read now
Paula Ministro & Diana Martins. (2017) Fecal biomarkers in inflammatory bowel disease: how, when and why?. Expert Review of Gastroenterology & Hepatology 11:4, pages 317-328.
Read now
Read now
Magdy El-Salhy. (2015) Recent advances in the diagnosis of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 9:9, pages 1161-1174.
Read now
Read now
Gian Paolo Caviglia, Rinaldo Pellicano & Marco Astegiano. (2015) Reply to: diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders. Scandinavian Journal of Gastroenterology 50:5, pages 623-624.
Read now
Read now
Mehmet Agilli, Fevzi Nuri Aydin, Yasemin Gulcan Kurt & Tuncer Cayci. (2015) Diagnostic power of fecal calprotectin in inflammatory and functional intestinal disorders. Scandinavian Journal of Gastroenterology 50:3, pages 376-377.
Read now
Read now
Articles from other publishers (43)
Laura A. Duckworth, Kimberly A. Sutton, Nurmohammad Shaikh, Jinli Wang, Carla Hall-Moore, Lori R. Holtz, Phillip I. Tarr & Ronald C. Rubenstein. (2024) Quantification of Enteric Dysfunction in Cystic Fibrosis: Inter- and Intraindividual Variability. The Journal of Pediatrics 265, pages 113800.
Crossref
Crossref
Elton Dajti, Leonardo Frazzoni, Veronica Iascone, Matteo Secco, Amanda Vestito, Lorenzo Fuccio, Leonardo Henry Eusebi, Pietro Fusaroli, Fernando Rizzello, Carlo Calabrese, Paolo Gionchetti, Franco Bazzoli & Rocco Maurizio Zagari. (2023) Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics 58:11-12, pages 1120-1131.
Crossref
Crossref
Abdulaziz S Asiri, Saad S Algarni, Anood Q Althubaiti, Mohammed A Alzubaidi, Jamal A Alghamdi & Ghazi A Almalki. (2023) Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review. Cureus.
Crossref
Crossref
Karoline Freeman, Brian H. Willis, Ronan Ryan, Sian Taylor-Phillips & Aileen Clarke. (2022) Comparing outcomes from tailored meta-analysis with outcomes from a setting specific test accuracy study using routine data of faecal calprotectin testing for inflammatory bowel disease. BMC Medical Research Methodology 22:1.
Crossref
Crossref
Magdalena Jendraszak, Mirosława Gałęcka, Małgorzata Kotwicka, Andreas Schwiertz, Aleksandra Regdos, Michalina Pazgrat-Patan & Mirosław Andrusiewicz. (2022) Impact of Biometric Patient Data, Probiotic Supplementation, and Selected Gut Microorganisms on Calprotectin, Zonulin, and sIgA Concentrations in the Stool of Adults Aged 18–74 Years. Biomolecules 12:12, pages 1781.
Crossref
Crossref
Pejman Rohani, Narjes Raja Beheshti, Hosein Alimadadi & Mohammad Hassan Sohouli. (2022) Association of fecal calprotectin level with eosinophilic gastrointestinal disease in Iranian pediatrics. Allergy, Asthma & Clinical Immunology 18:1.
Crossref
Crossref
Burcu Güven, Fatma İssi, Elif Sağ, Kurtuluş Buruk & Murat Çakır. (2022) Impact of Fecal Calprotectin Measurement for Inflammatory Bowel Disease in Children with Alarm Symptoms. The Journal of Pediatric Research 9:2, pages 126-131.
Crossref
Crossref
Yuanbin Liu & Mingkai Chen. (2022) Insights into the underlying mechanisms and clinical management of microscopic colitis in relation to other gastrointestinal disorders. Gastroenterology Report 10.
Crossref
Crossref
Muhammad Raheel Anjum, Jodie Chalmers, Rizwana Hamid & Neil Rajoriya. (2021) COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future. World Journal of Gastroenterology 27:44, pages 7625-7648.
Crossref
Crossref
Aslı Aksu Çerman, Ezgi Aktaş Karabay, Hazel Ezgi Kaya, Filiz Türe Özdemir, Ezgi Özkur, Yasemin Erdem & İlknur Kıvanç Altunay. (2021) Evaluation of fecal calprotectin as a marker of gastrointestinal inflammation in rosacea: A case‐control study. Dermatologic Therapy 34:3.
Crossref
Crossref
James P. Campbell, Claudia Zierold, Ashli M. Rode, Frank A. Blocki & Byron P. Vaughn. (2021) Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome. Journal of Clinical Gastroenterology 55:3, pages 239-243.
Crossref
Crossref
Henrik Hovstadius, David Lundgren & Pontus Karling. (2021) Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study. Inflammatory Intestinal Diseases 6:2, pages 101-108.
Crossref
Crossref
Francisco Guilherme Cancela e Penna, Rodrigo Macedo Rosa, Pedro Ferrari Sales da Cunha, Stella Cristina Silva de Souza & Maria de Lourdes de Abreu Ferrari. (2020) Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease. BMC Gastroenterology 20:1.
Crossref
Crossref
Fatemeh Khaki-Khatibi, Durdi Qujeq, Mehrdad Kashifard, Soheila Moein, Mahmood Maniati & Mostafa Vaghari-Tabari. (2020) Calprotectin in inflammatory bowel disease. Clinica Chimica Acta 510, pages 556-565.
Crossref
Crossref
Fernando Bermejo, Alicia Algaba, Daniel Bonillo, Laura Jiménez, Antonio Guardiola-Arévalo, María Pacheco, Ángel Castaño & Iván Guerra. (2020) Limitaciones de la determinación de calprotectina fecal en pacientes con colitis ulcerosa y pólipos inflamatorios. Gastroenterología y Hepatología 43:2, pages 73-78.
Crossref
Crossref
Fernando Bermejo, Alicia Algaba, Daniel Bonillo, Laura Jiménez, Antonio Guardiola-Arévalo, María Pacheco, Ángel Castaño & Iván Guerra. (2020) Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps. Gastroenterología y Hepatología (English Edition) 43:2, pages 73-78.
Crossref
Crossref
Christopher Andrew Lamb, Nicholas A Kennedy, Tim Raine, Philip Anthony Hendy, Philip J Smith, Jimmy K Limdi, Bu’Hussain Hayee, Miranda C E Lomer, Gareth C Parkes, Christian Selinger, Kevin J Barrett, R Justin Davies, Cathy Bennett, Stuart Gittens, Malcolm G Dunlop, Omar Faiz, Aileen Fraser, Vikki Garrick, Paul D Johnston, Miles Parkes, Jeremy Sanderson, Helen Terry, Daniel R Gaya, Tariq H Iqbal, Stuart A Taylor, Melissa Smith, Matthew Brookes, Richard Hansen & A Barney Hawthorne. (2019) British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 68:Suppl 3, pages s1-s106.
Crossref
Crossref
Pawel Petryszyn, Aleksandra Staniak, Agnieszka Wolosianska & Pawel Ekk-Cierniakowski. (2019) Faecal calprotectin as a diagnostic marker of inflammatory bowel disease in patients with gastrointestinal symptoms: meta-analysis. European Journal of Gastroenterology & Hepatology 31:11, pages 1306-1312.
Crossref
Crossref
Alonso Carrasco-Labra, Lyubov Lytvyn, Yngve Falck-Ytter, Christina M. Surawicz & William D. Chey. (2019) AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D). Gastroenterology 157:3, pages 859-880.
Crossref
Crossref
Su Jin Jeong. (2019) The role of fecal calprotectin in pediatric disease. Korean Journal of Pediatrics 62:8, pages 287-291.
Crossref
Crossref
Gian Paolo Caviglia, Chiara Rosso, Davide G. Ribaldone, Francesca Dughera, Sharmila Fagoonee, Marco Astegiano & Rinaldo Pellicano. (2019) Physiopathology of intestinal barrier and the role of zonulin. Minerva Biotecnologica 31:3.
Crossref
Crossref
Prianka Gajula & Eamonn M. Quigley. (2019) Overlapping irritable bowel syndrome and inflammatory bowel disease. Minerva Gastroenterologica e Dietologica 65:2.
Crossref
Crossref
Karoline Freeman, Brian H Willis, Hannah Fraser, Sian Taylor-Phillips & Aileen Clarke. (2019) Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy. BMJ Open 9:3, pages e027428.
Crossref
Crossref
Gian Paolo Caviglia, Francesca Dughera, Davide G. Ribaldone, Chiara Rosso, Maria L. Abate, Rinaldo Pellicano, Francesca Bresso, Antonina Smedile, Giorgio M. Saracco & Marco Astegiano. (2019) Serum zonulin in patients with inflammatory bowel disease: a pilot study. Minerva Medica 110:2.
Crossref
Crossref
Elena Mosso, Valentina Boano, Mario Grassini, Edda Battaglia & Rinaldo Pellicano. (2019) Microscopic colitis: a narrative review with clinical approach. Minerva Gastroenterologica e Dietologica 65:1.
Crossref
Crossref
Chiara Rosso, Luca Cabianca & Fabrizio M. Gili. (2019) Non-invasive markers to detect colorectal cancer in asymptomatic population. Minerva Biotecnologica 31:1.
Crossref
Crossref
Afrin Kamal, Ruthvik Padival & Bret Lashner. (2018) Inflammatory Bowel Disease and Irritable Bowel Syndrome: What to Do When There Is an Overlap. Inflammatory Bowel Diseases 24:12, pages 2479-2482.
Crossref
Crossref
Maria Gloria Mumolo, Lorenzo Bertani, Linda Ceccarelli, Gabriella Laino, Giorgia Di Fluri, Eleonora Albano, Gherardo Tapete & Francesco Costa. (2018) From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. World Journal of Gastroenterology 24:33, pages 3681-3694.
Crossref
Crossref
Taghi Amiriani, Sima Besharat, Mohammad Dadjou, Gholamreza Roshandel, HoneySadat Mirkarimi, Faezeh Salamat & Hamidreza Joshaghani. (2018) Assessing the Correlation of Fecal Calprotectin and the Clinical Disease Activity Index in Patients With Ulcerative Colitis. Gastroenterology Nursing 41:3, pages 201-205.
Crossref
Crossref
T S Chew & J C Mansfield. (2018) Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review. Frontline Gastroenterology 9:1, pages 23-28.
Crossref
Crossref
Laura Francesca Pisani, Gian Eugenio Tontini, Beatrice Marinoni, Vincenzo Villanacci, Barbara Bruni, Maurizio Vecchi & Luca Pastorelli. (2017) Biomarkers and Microscopic Colitis: An Unmet Need in Clinical Practice. Frontiers in Medicine 4.
Crossref
Crossref
Thomas G. Cotter, Moritz Binder, Eugene P. Harper, Thomas C. Smyrk & Darrell S. Pardi. (2017) Optimization of a Scoring System to Predict Microscopic Colitis in a Cohort of Patients With Chronic Diarrhea. Journal of Clinical Gastroenterology 51:3, pages 228-234.
Crossref
Crossref
Sjoerd G. Elias, Liselotte Kok, Ben J.M. Witteman, Jelle G. Goedhard, Mariëlle J.L. Romberg-Camps, Jean W.M. Muris, Niek J. de Wit & Karel G.M. Moons. (2017) Published diagnostic models safely excluded colorectal cancer in an independent primary care validation study. Journal of Clinical Epidemiology 82, pages 149-157.e8.
Crossref
Crossref
Yamile Zabana, Carme Ferrer, Montserrat Aceituno, Antonio Salas & Fernando Fernández-Bañares. (2017) Colitis microscópica: avances para una mejor identificación en los pacientes con diarrea crónica. Gastroenterología y Hepatología 40:2, pages 107-116.
Crossref
Crossref
Yamile Zabana, Carme Ferrer, Montserrat Aceituno, Antonio Salas & Fernando Fernández-Bañares. (2017) Advances for improved diagnosis of microscopic colitis in patients with chronic diarrhoea. Gastroenterología y Hepatología (English Edition) 40:2, pages 107-116.
Crossref
Crossref
Hana Manceau, Valérie Chicha-Cattoir, Hervé Puy & Katell Peoc’h. (2017) Fecal calprotectin in inflammatory bowel diseases: update and perspectives. Clinical Chemistry and Laboratory Medicine (CCLM) 55:4.
Crossref
Crossref
Anne Depince-Berger, Clara Cremilieux, Melanie Rinaudo-Gaujous, Christian Genin, Benedicte de Freminville, Claude Lambert, J. Bruneau & Stephane Paul. (2016) A Difficult and Rare Diagnosis of Autoimmune Enteropathy in a Patient Affected by Down Syndrome. Journal of Clinical Immunology 36:5, pages 423-428.
Crossref
Crossref
Vineet S. Gudsoorkar & Eamonn M.M. Quigley. (2016) Distinguishing Microscopic Colitis From Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology 14:5, pages 669-670.
Crossref
Crossref
Eamonn M. M. Quigley. (2015) Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?. Therapeutic Advances in Gastroenterology 9:2, pages 199-212.
Crossref
Crossref
F. Fernández-Bañares, M. J. Casanova, Y. Arguedas, B. Beltrán, D. Busquets, J. M. Fernández, L. Fernández-Salazar, E. García-Planella, D. Guagnozzi, A. J. Lucendo, N. Manceñido, I. Marín-Jiménez, M. Montoro, M. Piqueras, V. Robles, A. Ruiz-Cerulla & J. P. Gisbert. (2016) Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group. Alimentary Pharmacology & Therapeutics 43:3, pages 400-426.
Crossref
Crossref
Nicholas J Talley. (2015) Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach?. Clinical and Translational Gastroenterology 6:7, pages e104.
Crossref
Crossref
Gerhard Rogler & Luc Biedermann. (2015) Clinical Utility of Biomarkers in IBD. Current Gastroenterology Reports 17:7.
Crossref
Crossref
Guido Trentadue & Gerard Dijkstra. (2015) Current understanding of alloimmunity of the intestinal graft. Current Opinion in Organ Transplantation 20:3, pages 286-294.
Crossref
Crossref